| 3/28/2024 | 30043100 | Biological product INSUNOVA-R (Regular), substance: Human insulin 100IU/ml (Human insulin derived from recombinant DNA), Box of 1 vial x 10 ml injection solution, Registration number: 890410037623 (QLSP-849-15), Lot: BF23006916, production: February 2024, | XXXXXXXXXX | 3000 | UNK | 5790 | India | NA |
| 3/25/2024 | 30043100 | Diamisu 70/30 Injection.Human Insulin (rDNA origin), 1000IU/10ml. Box of 1 vial x 10ml; Injection suspension. Batch: 029PA7, NSX: 02/2024, Expiry date: 02/2026, Registration number: QLSP-1051-17 .HSX: Getz Pharma (PVT) Ltd. FOC | XXXXXXXXXX | 1500 | UNK | 3675 | Pakistan | NA |
| 3/25/2024 | 30043100 | Diamisu 70/30 Injection.Human Insulin (rDNA origin), 1000IU/10ml. Box of 1 vial x 10ml; Injection suspension. Batch: 029PA7, NSX: 02/2024, Expiry date: 02/2026, Registration number: QLSP-1051-17 .HSX: Getz Pharma (PVT) Ltd. | XXXXXXXXXX | 5470 | UNK | 13401.5 | Pakistan | NA |
| 3/25/2024 | 30043100 | Diamisu 70/30 Injection.Human Insulin (rDNA origin), 1000IU/10ml. Box of 1 vial x 10ml; Injection suspension. Batch: 028PA7, NSX: 02/2024, Expiry date: 02/2026, Registration number: QLSP-1051-17 .HSX: Getz Pharma (PVT) Ltd. | XXXXXXXXXX | 24530 | UNK | 60098.5 | Pakistan | NA |
| 3/15/2024 | 30043100 | Diabetes medicine WOSULIN 30/70 (INSULIN HUMAN RECOMBINANT 100IU/ML). Box of 01 syringe of 03ml. Visa:VN-13913-11. Lot number: DZ10101/02/07/08/14. Production: January 2024. HD:01/2026. TC: BP | XXXXXXXXXX | 100000 | UNA | 250000 | India | NA |
| 3/13/2024 | 30043100 | Biological product INSUNOVA-N (NPH), substance: Human insulin (Human insulin derived from recombinant DNA) 100IU/ml, Box of 1 vial x 10ml; Injection suspension, Registration number: QLSP-848-15, Lot:BF23006795, production: January 2024, hd: December 2026 | XXXXXXXXXX | 10000 | UNK | 37100 | India | NA |
| 3/13/2024 | 30043100 | Biological product INSUNOVA-R (Regular), substance: Human insulin 100IU/ml (Human insulin derived from recombinant DNA), Box of 1 vial x 10 ml injection solution, Registration number: 890410037623 (QLSP-849-15), Lot: BF23005664, sx:07/2023, hd:06/2026 | XXXXXXXXXX | 1980 | UNK | 4118.4 | India | NA |
| 3/12/2024 | 30043100 | Modern medicine: Insulatard Flexpen (Insulin Human 300 IU/3ml). Injectable suspension. Box contains 5 x 3ml prefilled pens. Lot: PT6CY65. Production: September 2023. HD: February 2026. Registration number: QLSP-1031-17. | XXXXXXXXXX | 1933 | UNK | 58395.93 | France | NA |
| 3/12/2024 | 30043100 | New medicine: Novorapid Flexpen (Insulin aspart (rDNA) 300 U/3ml). Injectable solution. Box of 5 injection pens containing medicine x 3ml. Lot: PT6CY68. Production: December 2023. HD: May 2026. Registration number: QLSP-963-16. | XXXXXXXXXX | 6132 | UNK | 267355.2 | France | NA |
| 3/4/2024 | 30043100 | Lantus solostar biological product (Insulin glargine 100 units/1ml). Injection solution in prefilled pen. Box of 5 x3ml injection pens. Batch 3F9322A NSX: 09/2023, Expiry date: 08/2026. Registration number: QLSP-857-15. | XXXXXXXXXX | 17480 | UNK | 622824.636 | Germany | NA |